Renaissance Capital logo

LUNG News

US IPO Weekly Recap: IPOs, SPACs, and direct listings, oh my!

PLTR

A total of 29 companies entered the public market this past week, the most ever in a single week. The week’s 11 IPOs were joined by 15 SPACs and three direct listings. Notable new IPO filings included TPG-backed antivirus provider McAfee (MCFE), Vista Equity’s IT software provider Datto (MSP), and three mortgage companies. ...read more

Pulmonx prices IPO at $19, above the upwardly revised range

LUNG

Pulmonx, which makes minimally invasive system to treat severe emphysema, raised $190 million by offering 10 million shares at $19, above the upwardly revised range of $17 to $18. The company had originally filed to sell 6.7 million shares at $14 to $16 before upsizing the deal on Wednesday. Pulmonx plans to list on the Nasdaq under the symbol LUNG. BofA Securities, Morgan Stanley...read more

Medical device maker Pulmonx increases proposed deal size by 75% ahead of $175 million IPO

LUNG

Pulmonx, which makes minimally invasive systems to treat severe emphysema, raised the proposed deal size for its upcoming IPO on Wednesday. The Redwood City, CA-based company now plans to raise $175 million by offering 10 million shares at a price range of $17 to $18. The company had previously filed to offer 6.7 million shares at a range of $14 to $16. At the midpoint of the...read more

US IPO Week Ahead: Palantir and Asana direct-list in 11 IPO week with tech, sports, and avocados

PLTR

Updated Monday, 9/28. 11 IPOs and two direct listings are scheduled to go public in the week ahead. The diverse group includes three foreign tech issuers, two biotechs, two US tech unicorns, a sporting goods retailer, an avocado supplier, a medical device maker, and a foreign education company. More SPACs will likely join the calendar as well. ...read more